Search
for
Sort by
Research 241–270 of 1000+
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Effects of the use of finasteride on prostate volume and serum PSA in young patients
- Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice
- Androgen Receptor Gene Polymorphism and Prostate Zonal Volumes in Australian and Chinese Men
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- Male pattern baldness and incidence of prostate cancer
- Does Androgenic Alopecia Aggravate the Risk of Prostate Cancer? Evidence from Mendelian Randomization
- Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues
- Keratinocyte-Specific Onset of Serine Protease BSSP Expression in Experimental Carcinogenesis
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth
- Diseases of the Canine Prostate Gland
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Androgenetic Alopecia and Risks of Overall and Aggressive Prostate Cancer: An Updated Systematic Review and Meta-Analysis
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA
- Re: Association of Treatment with 5α-Reductase Inhibitors with Time to Diagnosis and Mortality in Prostate Cancer
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Direct cellular reprogramming enables development of viral T antigen–driven Merkel cell carcinoma in mice
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Finasteride
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Endocrinology of the Aging Prostate: Current Concepts
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis